Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Jan;75(1):18–24.

Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

B Combe 1, M Rucheton 1, H Graafland 1, V Lussiez 1, C Brunel 1, J Sany 1
PMCID: PMC1541873  PMID: 2702772

Abstract

Antibodies to Sm and RNP antigens have been detected by immunoblotting and immunoprecipitation of small nuclear ribonucleoproteins in 168 sera from patients with connective tissue diseases previously characterized by immunodiffusion. Anti-RNP and anti-Sm antibodies immunoprecipitated U1 and U1-U6 snRNA respectively. By immunoblotting anti-Sm reacted with B-B' and D polypeptides and we have distinguished two types of anti-RNP sera: 1) 'full spectrum' anti-RNP sera reacted with the 68 kD, A, C and B-B' polypeptides; 2) 'partially reactive' anti-RNP sera reacted with various combinations of these polypeptides but not the four of them. A strong specificity of anti-Sm antibodies for systemic lupus erythematosus (SLE) was found with all three methods but immunoblotting was more sensitive and detected anti-Sm in 76% of SLE sera. Sera containing a high titer of 'full spectrum' anti-RNP without anti-Sm activity were only detected in mixed connective tissue disease (MCTD) whereas anti-68 kD antibodies alone seemed to be less specific. This strong association between 'full spectrum' anti-RNP antibodies and MCTD supports the hypothesis that MCTD is a distinct clinical entity associated with a specific serologic marker.

Full text

PDF
18

Images in this article

22Fig. 1
on p.22

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcon-Segovia D. Symptomatic Sjögren's syndrome in mixed connective tissue disease. J Rheumatol. 1976 Jun;3(2):191–195. [PubMed] [Google Scholar]
  2. Barada F. A., Jr, Andrews B. S., Davis J. S., 4th, Taylor R. P. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum. 1981 Oct;24(10):1236–1244. doi: 10.1002/art.1780241003. [DOI] [PubMed] [Google Scholar]
  3. Bohan A., Peter J. B., Bowman R. L., Pearson C. M. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977 Jul;56(4):255–286. doi: 10.1097/00005792-197707000-00001. [DOI] [PubMed] [Google Scholar]
  4. Brunel C., Lelay M. N. Two-dimensional analysis of proteins associated with heterogenous nuclear RNA in various animal cell lines. Eur J Biochem. 1979 Sep;99(2):273–283. doi: 10.1111/j.1432-1033.1979.tb13254.x. [DOI] [PubMed] [Google Scholar]
  5. Fox R. I., Robinson C. A., Curd J. G., Kozin F., Howell F. V. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum. 1986 May;29(5):577–585. doi: 10.1002/art.1780290501. [DOI] [PubMed] [Google Scholar]
  6. HAMARD M., CANNAT A., SELIGMANN M. LA RECHERCHE D'ANTICORPS ANTI-NUCL'EAIRES PAR IMMUNOFLUORESCENCE. (ETUDE DE 1430 S'ERUMS) Rev Fr Etud Clin Biol. 1964 Aug-Sep;9:716–728. [PubMed] [Google Scholar]
  7. Habets W. J., de Rooij D. J., Hoet M. H., van de Putte L. B., van Venrooij W. J. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol. 1985 Feb;59(2):457–466. [PMC free article] [PubMed] [Google Scholar]
  8. Holian J., Griffiths I. D., Glass D. N., Maini R. N., Scott J. T. Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 1975 Oct;34(5):438–443. doi: 10.1136/ard.34.5.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kinlaw C. S., Robberson B. L., Berget S. M. Fractionation and characterization of human small nuclear ribonucleoproteins containing U1 and U2 RNAs. J Biol Chem. 1983 Jun 10;258(11):7181–7189. [PubMed] [Google Scholar]
  10. Laemmli U. K., Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol. 1973 Nov 15;80(4):575–599. doi: 10.1016/0022-2836(73)90198-8. [DOI] [PubMed] [Google Scholar]
  11. Lerner M. R., Steitz J. A. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5495–5499. doi: 10.1073/pnas.76.11.5495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mimori T., Hinterberger M., Pettersson I., Steitz J. A. Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with scleroderma-polymyositis overlap syndrome. J Biol Chem. 1984 Jan 10;259(1):560–565. [PubMed] [Google Scholar]
  13. Munves E. F., Schur P. H. Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum. 1983 Jul;26(7):848–853. doi: 10.1002/art.1780260705. [DOI] [PubMed] [Google Scholar]
  14. NECHAEVA I. D. [Use of thio TEPA in complex therapy of patients with malignant tumors of the ovary]. Vopr Onkol. 1962;8(6):41–48. [PubMed] [Google Scholar]
  15. Notman D. D., Kurata N., Tan E. M. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med. 1975 Oct;83(4):464–469. doi: 10.7326/0003-4819-83-4-464. [DOI] [PubMed] [Google Scholar]
  16. Pettersson I., Hinterberger M., Mimori T., Gottlieb E., Steitz J. A. The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem. 1984 May 10;259(9):5907–5914. [PubMed] [Google Scholar]
  17. Pettersson I., Wang G., Smith E. I., Wigzell H., Hedfors E., Horn J., Sharp G. C. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study. Arthritis Rheum. 1986 Aug;29(8):986–996. doi: 10.1002/art.1780290807. [DOI] [PubMed] [Google Scholar]
  18. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  19. Reeves W. H., Fisher D. E., Wisniewolski R., Gottlieb A. B., Chiorazzi N. Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins. N Engl J Med. 1986 Jul 10;315(2):105–111. doi: 10.1056/NEJM198607103150207. [DOI] [PubMed] [Google Scholar]
  20. Rucheton M., Graafland H., Fanton H., Ursule L., Ferrier P., Larsen C. J. Presence of circulating antibodies against gag-gene MuLV proteins in patients with autoimmune connective tissue disorders. Virology. 1985 Jul 30;144(2):468–480. doi: 10.1016/0042-6822(85)90287-9. [DOI] [PubMed] [Google Scholar]
  21. Scopelitis E., Biundo J. J., Jr, Alspaugh M. A. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum. 1980 Mar;23(3):287–293. doi: 10.1002/art.1780230304. [DOI] [PubMed] [Google Scholar]
  22. Sharp G. C. Anti-nRNP and anti-Sm antibodies. Arthritis Rheum. 1982 Jul;25(7):757–760. doi: 10.1002/art.1780250708. [DOI] [PubMed] [Google Scholar]
  23. Sharp G. C., Irvin W. S., May C. M., Holman H. R., McDuffie F. C., Hess E. V., Schmid F. R. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med. 1976 Nov 18;295(21):1149–1154. doi: 10.1056/NEJM197611182952101. [DOI] [PubMed] [Google Scholar]
  24. Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972 Feb;52(2):148–159. doi: 10.1016/0002-9343(72)90064-2. [DOI] [PubMed] [Google Scholar]
  25. Sri-Widada J., Graafland H., Dietz R., Brunel C., Cathala G., Jeanteur P. A human auto-immune antibody specifically recognizing initiator methionine tRNA from yeast and higher eucaryotes. Biochem Biophys Res Commun. 1986 Aug 29;139(1):275–280. doi: 10.1016/s0006-291x(86)80109-7. [DOI] [PubMed] [Google Scholar]
  26. Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/s0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
  27. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  28. Williams D. G., Stocks M. R., Charles P. J., Maini R. N. Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Immunol Methods. 1986 Jul 11;91(1):65–73. doi: 10.1016/0022-1759(86)90103-1. [DOI] [PubMed] [Google Scholar]
  29. Williamson G. G., Pennebaker J., Boyle J. A. Clinical characteristics of patients with rheumatic disorders who possess antibodies against ribonucleoprotein particles. Arthritis Rheum. 1983 Apr;26(4):509–515. doi: 10.1002/art.1780260409. [DOI] [PubMed] [Google Scholar]
  30. van Venrooij W. J., Habets W. J. Detection of nuclear antigens recognized by human autoantibodies. Scand J Rheumatol Suppl. 1985;56:32–41. doi: 10.3109/03009748509102058. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES